F. Kerangueven et al., LOSS OF HETEROZYGOSITY IN HUMAN BREAST CARCINOMAS IN THE ATAXIA-TELANGIECTASIA, COWDEN DISEASE AND BRCA1 GENE REGIONS, Oncogene, 14(3), 1997, pp. 339-347
To appreciate the involvement of known or potential susceptibility gen
es in sporadic breast tumors, we have searched for chromosomal deletio
ns by studying loss of heterozygosity (LOH) at 43 microsatellite (CA)(
n) markers from human chromosomes 10, 11 and 17, in 115 unselected con
secutive samples of breast carcinoma with particular emphasis on speci
fic regions. No site of consistent LOH was identified on chromosome 10
. Five regions of LOH were contained within bands q22-24 of chromosome
11 for which nearly 50% of the tumors had LOH at at least one marker.
This region is thus a major site of deletion in breast cancer and sev
eral tumor suppressor genes seem to be involved. One of them may be th
e ataxia telangiectasia (ATM) gene which is located in one of the affe
cted regions. Five regions of LOH, one of which is within the BRCA1 ge
ne area, were recognized along chromosome 17. LOH at three of these re
gions were found in highly proliferative tumors, When combined with a
previous study of chromosome 13 with emphasis on BRCA2 and Rb1 genes,
this work allowed to distinguish a total of 12 regions of LOH, variabl
y affected in breast tumors and correlated with prognostic parameters.